Literature DB >> 18558433

Structural basis of cholecystokinin receptor binding and regulation.

Laurence J Miller1, Fan Gao.   

Abstract

Two structurally-related guanine nucleotide-binding protein-coupled receptors for two related peptides, cholecystokinin (CCK) and gastrin, have evolved to exhibit substantial diversity in specificity of ligand recognition, in their molecular basis of binding these ligands, and in their mechanisms of biochemical and cellular regulation. Consistent with this, the CCK1 and CCK2 receptors also play unique and distinct roles in physiology and pathophysiology. The paradigms for ligand recognition and receptor regulation and function are reviewed in this article, and should be broadly applicable to many members of this remarkable receptor superfamily. This degree of specialization is instructive and provides an encouraging basis for the diversity of potential drugs targeting these receptors and their actions that can be developed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18558433      PMCID: PMC2570585          DOI: 10.1016/j.pharmthera.2008.05.001

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  93 in total

1.  Single amino acid substitution of serine82 to asparagine in first intracellular loop of human cholecystokinin (CCK)-B receptor confers full cyclic AMP responses to CCK and gastrin.

Authors:  S V Wu; M Yang; D Avedian; M Birnbaumer; J H Walsh
Journal:  Mol Pharmacol       Date:  1999-05       Impact factor: 4.436

2.  Stimulation of both CCK-A and CCK-B receptors activates MAP kinases in AR42J and receptor-transfected CHO cells.

Authors:  A Dabrowski; K M Detjen; C D Logsdon; J A Williams
Journal:  Digestion       Date:  1997       Impact factor: 3.216

3.  Binding sites and transduction process of the cholecystokininB receptor: involvement of highly conserved aromatic residues of the transmembrane domains evidenced by site-directed mutagenesis.

Authors:  A Jagerschmidt; N Guillaume; B P Roques; F Noble
Journal:  Mol Pharmacol       Date:  1998-05       Impact factor: 4.436

4.  Direct identification of a second distinct site of contact between cholecystokinin and its receptor.

Authors:  E M Hadac; D I Pinon; Z Ji; E L Holicky; R M Henne; T P Lybrand; L J Miller
Journal:  J Biol Chem       Date:  1998-05-22       Impact factor: 5.157

5.  Role of the extracellular domains of the cholecystokinin receptor in agonist binding.

Authors:  S Silvente-Poirot; C Escrieut; S A Wank
Journal:  Mol Pharmacol       Date:  1998-08       Impact factor: 4.436

6.  Identification of a domain in the carboxy terminus of CCK receptor that affects its intracellular trafficking.

Authors:  W Y Go; E L Holicky; E M Hadac; R V Rao; L J Miller
Journal:  Am J Physiol       Date:  1998-07

7.  Minor modifications of a cholecystokinin-B/gastrin receptor non-peptide antagonist confer a broad spectrum of functional properties.

Authors:  M Beinborn; S M Quinn; A S Kopin
Journal:  J Biol Chem       Date:  1998-06-05       Impact factor: 5.157

8.  Met-195 of the cholecystokinin-A receptor interacts with the sulfated tyrosine of cholecystokinin and is crucial for receptor transition to high affinity state.

Authors:  V Gigoux; C Escrieut; S Silvente-Poirot; B Maigret; L Gouilleux; J A Fehrentz; D Gully; L Moroder; N Vaysse; D Fourmy
Journal:  J Biol Chem       Date:  1998-06-05       Impact factor: 5.157

9.  CCK receptor dysfunction in muscle membranes from human gallbladders with cholesterol stones.

Authors:  Z L Xiao; Q Chen; J Amaral; P Biancani; R T Jensen; J Behar
Journal:  Am J Physiol       Date:  1999-06

10.  Direct identification of the agonist binding site in the human brain cholecystokininB receptor.

Authors:  J Anders; M Blüggel; H E Meyer; R Kühne; A M ter Laak; E Kojro; F Fahrenholz
Journal:  Biochemistry       Date:  1999-05-11       Impact factor: 3.162

View more
  23 in total

1.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

2.  Development of a highly selective allosteric antagonist radioligand for the type 1 cholecystokinin receptor and elucidation of its molecular basis of binding.

Authors:  Maoqing Dong; Ashton M Vattelana; Polo C-H Lam; Andrew J Orry; Ruben Abagyan; Arthur Christopoulos; Patrick M Sexton; David R Haines; Laurence J Miller
Journal:  Mol Pharmacol       Date:  2014-10-15       Impact factor: 4.436

Review 3.  Metabolic Actions of the Type 1 Cholecystokinin Receptor: Its Potential as a Therapeutic Target.

Authors:  Laurence J Miller; Aditya J Desai
Journal:  Trends Endocrinol Metab       Date:  2016-05-04       Impact factor: 12.015

4.  Effect of Salvia miltiorrhiza pretreatment on the CCK and VIP expression in hepatic ischemia-reperfusion-induced digestive tract congestion.

Authors:  Zhi-Yong Zhang; Xiao-Ping Chen; Qi-Ping Lu
Journal:  Front Med China       Date:  2010-05-10

5.  Molecular basis for binding and subtype selectivity of 1,4-benzodiazepine antagonist ligands of the cholecystokinin receptor.

Authors:  Erin E Cawston; Polo C H Lam; Kaleeckal G Harikumar; Maoqing Dong; Alicja M Ball; Mary Lou Augustine; Eyup Akgün; Philip S Portoghese; Andrew Orry; Ruben Abagyan; Patrick M Sexton; Laurence J Miller
Journal:  J Biol Chem       Date:  2012-03-30       Impact factor: 5.157

Review 6.  Cholecystokinin-induced satiety, a key gut servomechanism that is affected by the membrane microenvironment of this receptor.

Authors:  A J Desai; M Dong; K G Harikumar; L J Miller
Journal:  Int J Obes Suppl       Date:  2016-11-16

7.  Development of a time-resolved fluorescence probe for evaluation of competitive binding to the cholecystokinin 2 receptor.

Authors:  N G R Dayan Elshan; Thanuja Jayasundera; Craig S Weber; Ronald M Lynch; Eugene A Mash
Journal:  Bioorg Med Chem       Date:  2015-02-26       Impact factor: 3.641

8.  Elucidation of the molecular basis of cholecystokinin Peptide docking to its receptor using site-specific intrinsic photoaffinity labeling and molecular modeling.

Authors:  Maoqing Dong; Polo C-H Lam; Delia I Pinon; Ruben Abagyan; Laurence J Miller
Journal:  Biochemistry       Date:  2009-06-16       Impact factor: 3.162

9.  Use of multidimensional fluorescence resonance energy transfer to establish the orientation of cholecystokinin docked at the type A cholecystokinin receptor.

Authors:  Kaleeckal G Harikumar; Fan Gao; Delia I Pinon; Laurence J Miller
Journal:  Biochemistry       Date:  2008-08-13       Impact factor: 3.162

10.  Direct demonstration of unique mode of natural peptide binding to the type 2 cholecystokinin receptor using photoaffinity labeling.

Authors:  Maoqing Dong; Laurence J Miller
Journal:  Peptides       Date:  2013-06-14       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.